Michelle Fredricks
Family Medicine · Baytown, TXNPI 1912909250
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 121 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 21.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,395 and has fallen 92.3% since, to $108 in 2022.
Across 121 payments — averaging $21.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$554
- Amarin Pharma, Inc.$388
- CSL Behring$159
- Johnson & Johnson$144
- Amgen$142
- AbbVie$117
- plus $1K from 27 others
What the payments were for
- Food & beverage$2,53099%
- Education$241%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 22 | $554 |
| Amarin Pharma, Inc. | 16 | $388 |
| CSL Behring | 8 | $159 |
| Johnson & Johnson | 12 | $144 |
| Amgen(2 entities) | 7 | $142 |
| AbbVie(2 entities) | 4 | $117 |
| Medtronic | 1 | $96 |
| Abbott | 4 | $88 |
| GSK | 4 | $77 |
| Boehringer Ingelheim | 4 | $77 |
| Novo Nordisk | 4 | $76 |
| Novartis | 4 | $73 |
| Neurocrine Biosciences, Inc. | 3 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $44 |
| Merck | 3 | $44 |
| Merz North America, Inc. | 2 | $42 |
| Bayer | 2 | $42 |
| Upsher-smith Laboratories LLC | 2 | $38 |
| Pfizer | 2 | $33 |
| Akcea Therapeutics, Inc. | 1 | $25 |
| Arbor Pharmaceuticals, Inc. | 2 | $23 |
| Nestle Healthcare Nutrition Inc. | 1 | $22 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $21 |
| Biohaven Pharmaceuticals, Inc. | 1 | $20 |
| Boston Scientific | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Vivus LLC | 1 | $16 |
| Scilex Pharmaceuticals Inc. | 1 | $15 |
| Kyowa Kirin, Inc. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
| Sanofi Pasteur Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,553 in reported general payments places this provider in the 75th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Baytown
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Bradley WassonArlington$734K
- Cynthia BrinsonAustin$402K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
- Sumit PerakathuHarlingen$342K
- Joel SolisMcAllen$324K
- Robert CampbellFort Worth$318K
- Jose LedezmaEdinburg$300K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.